Drug Profile


Alternative Names: CI 946; GOE 4942; PD 117818

Latest Information Update: 06 Mar 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Goedecke
  • Class Antiepileptic drugs; Neuroprotectants; Small molecules; Thiazoles
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 06 Mar 2002 Discontinued - Clinical-Phase-Unknown for Epilepsy in USA (PO)
  • 28 Jun 1999 Discontinued-Clinical for Epilepsy in Germany (PO)
  • 28 Jun 1999 Discontinued-Clinical for Epilepsy in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top